Schlanger David J reported option exercise involving 3,400 shares of Progyny, Inc. at $0.91 for $3.09k on Nov 5, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Executive Chairman
Executive Chairman
Filed Nov 9, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$3,094Shares × reported price
Shares traded
3,400Common Stock
Price per share
$0.91Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
241,862Direct
Trade date
Nov 5, 2026Option exercise
Filed
Nov 9, 2026, 9:55 PM ET5-day reporting delay
Accession
0001551306-26-000174Code M · Transaction 396641
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 5, 2026Option exercise3,400$0.00$0Trade 396645
Nov 9, 2026Option exercise161,208$0.00$0Trade 396646
Nov 9, 2026Option exercise161,208$0.91$146,699.28Trade 396643
Nov 5, 2026Sell3,400$35.22−$119,751.06Trade 396642
Nov 9, 2026Sell161,208$35.73−$5,759,365.37Trade 396644
6 transaction rows in this filing. Joint filers share the same rows.

PGNY price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
PGNY · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 17, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −28%1w ago −21%1d ago −16%
Returns since7d30d90d180d1y

Footnotes in full

F1: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 2, 2026. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4: These options are fully vested and exercisable.